The SDRC Cell Culture and Molecular Technology Core (CCMTC) has played an important role in facilitating skin-based research activity at the Case School of Medicine throughout its fifteen year history. During this time, the core has provided basic services and training, and also state-of-the-art services, facilities and expertise. The CCMTC has now developed into a major hub of research activity on campus and has an active role in introducing new investigators to work on dermatological disease. The core is heavily engaged in providing a wide range of cultured skin cells to investigators, and in providing training in cell culture methodology and molecular biology technology. The three major missions of the CCMTC include the following.
Specific Aim I A primary goal of the CCMTC is to provide state-of-the-art cell culture and molecular technology services and expertise, and cost savings to the Skin Diseases Research Center (SDRC) membership at the Case Western Reserve University School of Medicine, and to the larger community of researchers affiliated with the Case School of Medicine. The CCMTC has been very successful in supplying investigators with new technology. This remains a core goal of the CCMTC. In response to the demands of a changing scientific environment, the core has historically added new state-ofthe- art technology as it becomes available. In addition to the substantial list of technology that is presently offered, we will now provide access, expertise and training in advanced real-time fluorescent imaging for visualization of intracellular protein-protein interaction (FRET, FRAP, etc.), chip array analysis, and proteomics.
Specific Aim 2 A major goal of the CCMTC, in conjunction with the other SDRC cores, is to provide cell and molecular technology, and expertise, that facilitates and encourages the translation of basic science projects to the bedside. A major goal of the SDRC is to serve as a conduit that benefits dermatologic therapy by bringing new diagnoistics and treatments to the bedside with the goal of improving patient care.
Specific Aim 3 The third goal of the CCMTC is to promote career development with a goal of retaining talented young Ph.D. and M.D. investigators in the dermatologic sciences. This is achieved by providing training to new investigators and senior investigators in technologies that will facilitate investigation of dermatologic diseases and by providing a forum for discussion of dematologic science.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Center Core Grants (P30)
Project #
5P30AR039750-19
Application #
7904825
Study Section
Special Emphasis Panel (ZAR1)
Project Start
Project End
Budget Start
2009-08-01
Budget End
2010-07-31
Support Year
19
Fiscal Year
2009
Total Cost
$148,110
Indirect Cost
Name
Case Western Reserve University
Department
Type
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Das, Lopa M; Binko, Amy M; Traylor, Zachary P et al. (2018) Defining the timing of 25(OH)D rescue following nitrogen mustard exposure. Cutan Ocul Toxicol 37:127-132
Griffith, Alexis D; Zaidi, Asifa K; Pietro, Ashley et al. (2018) A requirement for slc15a4 in imiquimod-induced systemic inflammation and psoriasiform inflammation in mice. Sci Rep 8:14451
Zaidi, Asifa K; Spaunhurst, Katrina; Sprockett, Daniel et al. (2018) Characterization of the facial microbiome in twins discordant for rosacea. Exp Dermatol 27:295-298
Bhaskaran, Natarajan; Liu, Zhihui; Saravanamuthu, Senthil S et al. (2018) Identification of Casz1 as a Regulatory Protein Controlling T Helper Cell Differentiation, Inflammation, and Immunity. Front Immunol 9:184
Mukherjee, Pranab K; Chandra, Jyotsna; Retuerto, Mauricio et al. (2018) Effect of alcohol-based hand rub on hand microbiome and hand skin health in hospitalized adult stem cell transplant patients: A pilot study. J Am Acad Dermatol 78:1218-1221.e5
Arbiser, Jack L; Nowak, Ron; Michaels, Kellie et al. (2017) Evidence for biochemical barrier restoration: Topical solenopsin analogs improve inflammation and acanthosis in the KC-Tie2 mouse model of psoriasis. Sci Rep 7:11198
Larkin, Emily; Hager, Christopher; Chandra, Jyotsna et al. (2017) The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation. Antimicrob Agents Chemother 61:
Hutnick, Melanie A; Ahsanuddin, Sayeeda; Guan, Linna et al. (2017) PEGylated Dendrimers as Drug Delivery Vehicles for the Photosensitizer Silicon Phthalocyanine Pc 4 for Candidal Infections. Biomacromolecules 18:379-385
Mukherjee, Pranab K; Funchain, Pauline; Retuerto, Mauricio et al. (2017) Metabolomic analysis identifies differentially produced oral metabolites, including the oncometabolite 2-hydroxyglutarate, in patients with head and neck squamous cell carcinoma. BBA Clin 7:8-15
Swindell, William R; Michaels, Kellie A; Sutter, Andrew J et al. (2017) Imiquimod has strain-dependent effects in mice and does not uniquely model human psoriasis. Genome Med 9:24

Showing the most recent 10 out of 403 publications